Help us improve the Gazette by taking this short survey —

Gazette Website Experience Survey

Notice Title

Consent to the Distribution of New Medicines

Publication Date
21 May 2026

Tags

Medicines Act Consent to the distribution of new medicines Health

Notice Number

2026-sl2698
Title
View PDF
File Type and Size
PDF (22 KB)

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:

Schedule

Product: AdiraMedica Fexofenadine Hydrochloride 120 (General Sale)
Active Ingredient: Fexofenadine hydrochloride 120mg
Dosage Form: Coated tablet
New Zealand Sponsor: AdiraMedica Pty Limited
Manufacturer: Sunglow Lifescience Private Limited, Kattankulam Village, India
   
Product: AdiraMedica Fexofenadine Hydrochloride 120 (Pharmacy Only)
Active Ingredient: Fexofenadine hydrochloride 120mg
Dosage Form: Coated tablet
New Zealand Sponsor: AdiraMedica Pty Limited
Manufacturer: Sunglow Lifescience Private Limited, Kattankulam Village, India
   
Product: AdiraMedica Fexofenadine Hydrochloride 180
Active Ingredient: Fexofenadine hydrochloride 180mg
Dosage Form: Coated tablet
New Zealand Sponsor: AdiraMedica Pty Limited
Manufacturer: Sunglow Lifescience Private Limited, Kattankulam Village, India


Dated this 18th day of May 2026.

CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).